JCDR - Register at Journal of Clinical and Diagnostic Research
Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X
Microbiology Section DOI : 10.7860/JCDR/2017/27201.10046
Year : 2017 | Month : Jun | Volume : 11 | Issue : 6 Full Version Page : DD05 - DD06

Native Valve Endocarditis Caused by Escherichia Coli

Thangam Menon1, Nandhakumar Balakrishnan2, Shanmugasundaram Somasundaram3, Prabu Dhandapani4

1 Professor and Head, Department of Microbiology, University of Madras, Chennai, Tamil Nadu, India.
2 Past Research Scholar, Department of Microbiology, University of Madras, Chennai, Tamil Nadu, India.
3 Professor (Retd), Department of Cardiology, Madras Medical College and General Hospital, Chennai, Tamil Nadu, India.
4 Assistant Professor, Department of Microbiology, University of Madras, Chennai, Tamil Nadu, India.


NAME, ADDRESS, E-MAIL ID OF THE CORRESPONDING AUTHOR: Dr. Thangam Menon, Professor and Head, Department of Microbiology, Dr. ALM PGIBMS, University of Madras, Taramani, Chennai-600113, Tamil Nadu, India.
E-mail: thangam56@gmail.com
Abstract

Escherichia coli is a rare cause of infective endocarditis. This report describes a case of native valve endocarditis caused by Escherichia coli in a 58-year-old male renal transplant patient who had a concurrent urinary tract infection caused by the same organism. The patient was successfully treated with antibiotics and recovered without surgical intervention.

Keywords

Case Report

A 58-year-old male attended a tertiary care hospital with a history of fever associated with chills and rigor of six weeks duration. He also complained of dyspnoea, cough, chest pain and palpitation. He had undergone a renal transplant four years ago for treatment of congenital polycystic kidney disease. He had mild renal insufficiency and compensated metabolic acidosis.

On physical examination, he was febrile (105ºF), blood pressure was 110/80 mmHg, and pulse rate 81 per min. The total leucocyte count was 4.8 x 103 cells/mm3 with 81% neutrophils, 11% lymphocytes, 1% eosinophils and 7% monocytes. The haemoglobin level was 10.0 gm/dL, erythrocyte sedimentation rate 134 mm for 1 hour, C-reactive protein 268 mg/dL, urea 53 mg/dL, creatinine 2.29 mg/ dL and random blood sugar was 163 mg/dL. The peripheral blood smear showed normocytic normochromic anaemia and neutrophilia with toxic granules. Routine examination of the urine showed marked proteinuria, microscopic haematuria and many pus cells and motile bacilli. The transthoracic echocardiogram demonstrated vegetation on the aortic valve and mild annular calcification without any evidence of pericardial effusion. The electrocardiogram showed normal sinus rhythm.

Blood cultures were done by collecting three consecutive blood samples at intervals of one hour. Approximately, 10 ml of venous blood was inoculated into 100 ml brain heart infusion broth supplemented with the 0.01% sodium polyanethol sulphonate (HiMedia Laboratories, Mumbai). The blood culture bottles were incubated at 37ºC for 18-24 hours and observed daily for signs of growth. Turbidity was noticed in all the three bottles within 18-24 hours and Gram-stained smears showed Gram-negative, pleomorphic, coccobacilli. The broth was subcultured on to 5% sheep blood agar and MacConkey agar and incubated at 37ºC. After 18 hours of incubation, MacConkey agar medium showed lactose-fermenting colonies, about 2-3 mm in diameter. Colonies on blood agar were grey and non-haemolytic. They were found to be Gram-negative, motile, pleomorphic, coccobacilli, which were oxidase negative and catalase positive and identified by standard biochemical tests [1] as Escherichia coli. Culture of the urine also grew Escherichia coli with a colony count of >105 CFU/ml.

Antimicrobial susceptibility testing was performed by the Kirby Bauer disc diffusion method as per CLSI recommendations [2]. The isolate was found to be sensitive to imipenem, moderately sensitive to amikacin, cefotaxime, ceftriaxone and resistant to netlimicin, ceftazidime, cefuroxime, ciprofloxacin, and levofloxacin.

The patient was treated with intravenous infusion of ceftriaxone 2 g twice daily for two weeks and amikacin 80 mg once daily for eight weeks. He responded well to treatment and was afebrile within 72 hours after initiation of therapy. Antibiotic treatment was continued for eight weeks. Repeat blood cultures were sterile.

Discussion

Escherichia coli has emerged in recent years as an increasingly important cause of morbidity and mortality in both immunocompetent and immunosuppressed persons. Nevertheless it remains an extremely uncommon cause of infective endocarditis [3]. The increase in the numbers of immunocompromised patients has led to a change in the spectrum of organisms causing native valve endocarditis. Escherichia coli is a common cause of urinary tract infections. The low incidence of endocarditis caused by this organism has been attributed to its inability to adhere to endocardium, and also to the fact that normal serum often has antibodies to Escherichiacoli [4]. Gram-negative bacteria are less sensitive to complement-mediated lysis and other humoral innate immune defences; they lack surface proteins that specifically bind host matrix molecules and prosthetic material which make them rare causative agents of infective endocarditis. However, they possess virulence factors such as adhesins, iron acquisition systems, and toxins which make them serious pathogens once they gain entry into a normally sterile extra intestinal site [5]. Endocarditis caused by Gram-negative organisms is associated with high mortality and significant morbidity and necessitates aggressive medical management and early surgical intervention. This patient had no history of cardiac disease and the source of the infection was likely to be the urinary tract. He responded well to antibiotic therapy and did not require surgical intervention.

Conclusion

Urinary tract infection appeared to be an important predisposing factor in the development of E. coli endocarditis in this patient who had no specific cardiac risk factors. Persistent fever in an immunocompromised patient with urinary tract infection despite specific antibiotic treatment should be investigated to rule out serious infections such as endocarditis.

References

[1]Farmer JJ, Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, Enterobacteriaceae: introduction and identification Manual of Clinical Microbiology 1999 7th editionWashington DCASM press:442-458.  [Google Scholar]

[2]CLSI Performance standards for antimicrobial susceptibility testing. CLSI document M100-S17 2007 Wayne, PAClinical and Laboratory Standards Institute  [Google Scholar]

[3]Johannes S, Escherichia coli endocarditis of the aortic valve with formation of a paravalvular abscess cavity Echocardiography 2005 22:126  [Google Scholar]

[4]Watanakunakorn C, Burket T, Infective endocarditis in a large community teaching hospital 1980-1990. A review of 210 episodes Medicine 2013 72:90-102.  [Google Scholar]

[5]Russo TA, Johnson JR, Proposal for a new inclusive definition for extraintestinal pathogenic isolates of Escherichia coli: ExPEC J Infect Dis 2000 181:1753-54.  [Google Scholar]